Search by Drug Name or NDC

    NDC 69097-0426-05 ENTECAVIR 0.5 mg/1 Details

    ENTECAVIR 0.5 mg/1

    ENTECAVIR is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cipla USA Inc.. The primary component is ENTECAVIR.

    Product Information

    NDC 69097-0426
    Product ID 69097-426_f11e1153-612f-4924-86b1-6739d755e3c1
    Associated GPIs 12352030000320
    GCN Sequence Number 058934
    GCN Sequence Number Description entecavir TABLET 0.5 MG ORAL
    HIC3 W5F
    HIC3 Description HEPATITIS B TREATMENT AGENTS
    GCN 24466
    HICL Sequence Number 032832
    HICL Sequence Number Description ENTECAVIR
    Brand/Generic Generic
    Proprietary Name ENTECAVIR
    Proprietary Name Suffix n/a
    Non-Proprietary Name ENTECAVIR
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name ENTECAVIR
    Labeler Name Cipla USA Inc.
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206872
    Listing Certified Through 2024-12-31

    Package

    NDC 69097-0426-05 (69097042605)

    NDC Package Code 69097-426-05
    Billing NDC 69097042605
    Package 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (69097-426-05)
    Marketing Start Date 2016-12-06
    NDC Exclude Flag N
    Pricing Information N/A